Drug-resistant microorganisms are one of the hottest topics of the 21st century. With the potential to cause nearly $100 trillion in damages to the world health and economy, the issue of infections untreatable by modern antibiotics is one that leaves many concerned and looking for solutions.
Anti-drug resistant technologies are a new generation of antimicrobials, that have been developed to combat drug-resistant microorganisms. Some involve the use of nanotechnology and light, while others involve the use of newly developed synthetic chemicals/drugs.
This technology offers a proprietary anti-drug resistant material/chemical technology, that can be customised into innovative formulations, for treatment of fungal, as well as gram positive and gram negative microbial infections, enabling protection to humans and animals.
This technology has the ability to prevent the development of anti-microbial resistant microbial, and has been tested in various applications from veterinary or animal health to feed formulations.
This technology carries the following properties:
Depending on the requirements and the application, this technology will need to be customised through material and chemical processes, in order to achieve the best results.
This technology can be applicable (but not limited) to the following:
Antimicrobial resistance (AMR) is an ability that microorganisms, such as bacteria and viruses, gain or develop over time to combat against antimicrobial technologies. According to the World Health Organisation (WHO), the use of antimicrobial technologies, such as antibiotics, antivirals and other chemicals, has been on the rise, and misuse or overuse of antimicrobials would accelerate the development of AMR. As a result, antimicrobials are slowly becoming ineffective, allowing the proliferation of AMR microorganisms (also called “superbugs”).
With new resistance mechanism emerging and spreading globally, which threatens our ability to treat common diseases and inevitably our very existence, there is a need for alternative and innovative forms of antimicrobial technology, especially anti-drug resistant ones, that would prevent AMR microorganisms from proliferating.